CAWM
RNXT icon

Capital Advisors Wealth Management’s RenovoRx RNXT Stock Holding History

Capital Advisors Wealth Management’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,000
Closed -$8.4K – 228
2025
Q4 		$8.4K Hold
10,000
– – ﹤0.01% 219
2025
Q3 		$12.7K Hold
10,000
– – ﹤0.01% 215
2025
Q2 		$13.2K Buy
+10,000
New +$11.4K ﹤0.01% 191

Other funds holding RNXT

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return
NPT
Nixon Peabody Trust Boston, Massachusetts $1.41B AUM 27.78% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

Capital Advisors Wealth Management's RNXT Position: Q1 2026 in Review

Capital Advisors Wealth Management sold out of RenovoRx (RNXT) in Q1 2026, closing a stake of 10,000 shares — an estimated $8.4K sold.

Capital Advisors Wealth Management first reported a position in RNXT in Q2 2025 and held it in 3 quarters. The position peaked at $13.2K in Q2 2025. 31 funds tracked by Wall St. Rank hold RNXT as of Q1 2026.

  • Capital Advisors Wealth Management reported no remaining RenovoRx position as of Q1 2026 after selling out during the quarter.
  • Capital Advisors Wealth Management sold 10,000 RenovoRx shares in Q1 2026, an estimated $8.4K.
  • Capital Advisors Wealth Management first reported a position in RenovoRx in Q2 2025 and held it in 3 quarters.
  • Capital Advisors Wealth Management's RenovoRx position peaked at $13.2K in Q2 2025.
  • 31 funds tracked by Wall St. Rank held RenovoRx as of Q1 2026.

Based on Capital Advisors Wealth Management's 13F filing for Q1 2026, filed 8 Apr 2026.